Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Michele Fox

Concepts (437)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hematopoietic Stem Cell Transplantation
31
2023
580
2.170
 Why?
Hematopoietic Stem Cells
21
2018
197
1.900
 Why?
Multiple Myeloma
44
2024
2990
1.810
 Why?
Bone Marrow Transplantation
27
2016
135
1.760
 Why?
Hematopoietic Stem Cell Mobilization
13
2018
58
1.410
 Why?
Antigens, CD34
20
2018
75
0.960
 Why?
Antineoplastic Combined Chemotherapy Protocols
16
2024
997
0.890
 Why?
Cell Separation
8
2013
92
0.800
 Why?
Blood Platelets
5
2017
253
0.790
 Why?
Purpura, Thrombotic Thrombocytopenic
3
2018
16
0.700
 Why?
Melphalan
7
2016
177
0.600
 Why?
Leukapheresis
5
2018
17
0.580
 Why?
Transplantation, Autologous
21
2013
480
0.580
 Why?
Fetal Blood
4
2023
66
0.570
 Why?
Myelodysplastic Syndromes
3
2013
78
0.540
 Why?
Graft vs Host Disease
15
2003
85
0.500
 Why?
Leukocytes, Mononuclear
5
2018
118
0.490
 Why?
Plasma Exchange
3
2015
25
0.480
 Why?
Humans
89
2024
50419
0.470
 Why?
Adult
47
2019
13561
0.450
 Why?
Middle Aged
42
2018
12579
0.430
 Why?
Flow Cytometry
6
2016
472
0.410
 Why?
Aged
32
2017
9738
0.400
 Why?
Transplantation Conditioning
9
2006
88
0.400
 Why?
Pregnant Women
1
2023
70
0.390
 Why?
Granulocyte Colony-Stimulating Factor
7
2012
63
0.390
 Why?
Killer Cells, Natural
3
2015
107
0.380
 Why?
Blood Component Removal
4
2018
10
0.380
 Why?
Female
49
2023
27053
0.370
 Why?
Chromosome Aberrations
5
2016
279
0.360
 Why?
Cell Proliferation
5
2018
980
0.350
 Why?
Male
46
2019
25866
0.350
 Why?
Immunotherapy, Adoptive
2
2015
161
0.340
 Why?
Transplantation, Homologous
13
2016
146
0.340
 Why?
Platelet Count
4
2017
65
0.330
 Why?
Blood Transfusion
3
2017
123
0.330
 Why?
Antigens, CD
10
2003
221
0.330
 Why?
Thalidomide
5
2016
375
0.320
 Why?
Antibodies
2
2016
151
0.310
 Why?
Blood Specimen Collection
1
2019
35
0.310
 Why?
Blood Volume
1
2019
68
0.310
 Why?
Education, Distance
1
2019
41
0.300
 Why?
Erythrocyte Transfusion
3
2015
52
0.300
 Why?
Clinical Laboratory Techniques
1
2018
28
0.290
 Why?
Cryopreservation
3
2010
33
0.290
 Why?
Obstetrics
1
2019
85
0.290
 Why?
Lymphoma
3
2018
66
0.280
 Why?
Leukemia
3
2013
65
0.280
 Why?
Cyclooxygenase Inhibitors
1
2017
38
0.280
 Why?
Blood Grouping and Crossmatching
1
2017
5
0.280
 Why?
Blood Coagulation
1
2017
59
0.270
 Why?
Leukocytes
3
2011
69
0.270
 Why?
Bone Marrow Cells
5
2004
195
0.260
 Why?
Follow-Up Studies
11
2024
2231
0.260
 Why?
Graft Survival
7
2011
160
0.260
 Why?
Aspirin
1
2017
112
0.260
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2017
120
0.260
 Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
2000
45
0.250
 Why?
Platelet Aggregation Inhibitors
1
2017
174
0.250
 Why?
Combined Modality Therapy
12
2014
640
0.240
 Why?
Hemoglobins, Abnormal
1
2015
4
0.240
 Why?
Heparin
1
2015
91
0.240
 Why?
Thrombocytopenia
1
2015
82
0.230
 Why?
Stem Cell Transplantation
2
2013
179
0.230
 Why?
Factor VIII
1
2014
23
0.230
 Why?
ADAM Proteins
1
2014
19
0.230
 Why?
Methotrexate
2
2001
76
0.220
 Why?
Anemia, Sickle Cell
1
2015
95
0.210
 Why?
Internship and Residency
1
2019
443
0.210
 Why?
Cancer Vaccines
3
2010
80
0.210
 Why?
Dendritic Cells
3
2010
135
0.210
 Why?
Prognosis
8
2018
1974
0.210
 Why?
Retrospective Studies
11
2018
6274
0.210
 Why?
Retroviridae
4
1997
9
0.210
 Why?
Neoplasm Recurrence, Local
3
2015
622
0.210
 Why?
Cell Count
7
2011
150
0.210
 Why?
Antiretroviral Therapy, Highly Active
1
2013
31
0.200
 Why?
Cytomegalovirus Infections
3
2001
37
0.200
 Why?
Cell Survival
7
2011
587
0.200
 Why?
Afibrinogenemia
1
2012
5
0.200
 Why?
Bone Marrow
8
1997
360
0.200
 Why?
Dexamethasone
6
2024
431
0.200
 Why?
Graft vs Tumor Effect
2
2006
3
0.190
 Why?
Treatment Outcome
19
2013
5265
0.190
 Why?
Leukemia, Myeloid
2
2000
44
0.190
 Why?
Adenoviridae Infections
1
2001
3
0.190
 Why?
Aldehyde Dehydrogenase
1
2011
25
0.190
 Why?
Gene Transfer Techniques
3
1997
41
0.190
 Why?
Lung Diseases, Fungal
1
2001
32
0.180
 Why?
Tamoxifen
1
2001
61
0.180
 Why?
Cyclophosphamide
8
2006
168
0.180
 Why?
Boronic Acids
2
2013
182
0.180
 Why?
Pyrazines
2
2013
187
0.180
 Why?
Plateletpheresis
1
2010
7
0.180
 Why?
Blood Preservation
1
2010
26
0.170
 Why?
Lymphoma, B-Cell
1
2000
49
0.170
 Why?
Immunosuppressive Agents
4
2014
227
0.170
 Why?
Blood Proteins
1
2010
83
0.170
 Why?
Myeloablative Agonists
3
2007
32
0.170
 Why?
Fever
1
2001
112
0.170
 Why?
Peripheral Blood Stem Cell Transplantation
3
2006
56
0.170
 Why?
Anaphylaxis
1
2010
70
0.170
 Why?
Genetic Vectors
4
1997
128
0.160
 Why?
Chromosomes, Human, Pair 1
2
2007
92
0.160
 Why?
Incidence
7
2017
1027
0.160
 Why?
Blood Cells
4
1994
47
0.160
 Why?
HIV Infections
1
2013
347
0.150
 Why?
Receptors, KIR
1
2008
12
0.150
 Why?
Etoposide
6
2006
77
0.150
 Why?
Gene Expression Regulation, Neoplastic
2
2016
831
0.150
 Why?
Disease-Free Survival
6
2016
439
0.140
 Why?
Cell Movement
2
2006
244
0.140
 Why?
Phosphotransferases (Alcohol Group Acceptor)
2
1995
23
0.140
 Why?
Immunoglobulins, Intravenous
3
1992
64
0.140
 Why?
Lymphocyte Transfusion
3
2003
12
0.130
 Why?
Risk Factors
7
2015
3712
0.130
 Why?
Breast Neoplasms
6
1995
1198
0.130
 Why?
Models, Genetic
1
2006
166
0.130
 Why?
Osteogenesis
2
2006
354
0.130
 Why?
Transformation, Genetic
1
1995
18
0.130
 Why?
Antineoplastic Agents
5
2012
1165
0.130
 Why?
Models, Statistical
1
2007
224
0.130
 Why?
Young Adult
4
2019
4075
0.120
 Why?
Time Factors
2
2010
2933
0.120
 Why?
Cytokines
2
2006
602
0.120
 Why?
Gene Expression Profiling
2
2007
1020
0.120
 Why?
Macrophages
1
2018
365
0.120
 Why?
Metaphase
3
2016
45
0.120
 Why?
Lymphocytes, Tumor-Infiltrating
1
1995
77
0.120
 Why?
Recurrence
4
2008
657
0.120
 Why?
Dimethyl Sulfoxide
2
2010
13
0.120
 Why?
Mycobacterium tuberculosis
1
2007
266
0.120
 Why?
Enzyme-Linked Immunosorbent Assay
2
2015
227
0.120
 Why?
CD8-Positive T-Lymphocytes
1
1995
127
0.120
 Why?
Models, Biological
2
2007
717
0.120
 Why?
Immunoglobulin G
3
2003
188
0.110
 Why?
Risk
2
2017
325
0.110
 Why?
Acute Disease
4
2013
374
0.110
 Why?
Postoperative Complications
2
2001
1030
0.110
 Why?
CD4-Positive T-Lymphocytes
1
1995
158
0.110
 Why?
Pregnancy
2
2023
2444
0.110
 Why?
Cytotoxicity Tests, Immunologic
2
2016
26
0.110
 Why?
Blood Banks
1
2023
16
0.100
 Why?
Neoplasms
4
2007
1248
0.100
 Why?
Sweet Syndrome
1
2003
11
0.100
 Why?
Bone Diseases
1
2004
96
0.100
 Why?
Osteoblasts
1
2006
463
0.100
 Why?
Prospective Studies
6
2016
2378
0.100
 Why?
Cyclosporine
1
2003
67
0.100
 Why?
Hemorrhage
2
2017
195
0.100
 Why?
Tacrolimus
1
2003
54
0.100
 Why?
Blood Group Incompatibility
1
2002
5
0.100
 Why?
ABO Blood-Group System
1
2002
15
0.100
 Why?
Universities
1
2023
168
0.100
 Why?
T-Lymphocytes
2
1998
325
0.090
 Why?
Kaplan-Meier Estimate
3
2007
462
0.090
 Why?
Coculture Techniques
3
2018
140
0.090
 Why?
Ovarian Neoplasms
1
1995
449
0.090
 Why?
Genetic Therapy
3
1995
120
0.090
 Why?
Lymphoma, Mantle-Cell
2
2001
14
0.090
 Why?
Cryoprotective Agents
2
1998
8
0.090
 Why?
Hodgkin Disease
2
2002
45
0.090
 Why?
Osteoclasts
1
2004
427
0.090
 Why?
Platelet Transfusion
2
2010
29
0.090
 Why?
Lymphocyte Depletion
3
1996
9
0.090
 Why?
Tissue Preservation
2
1998
8
0.090
 Why?
Cyclosporins
2
1991
11
0.090
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
3
2012
56
0.080
 Why?
T-Lymphocytes, Cytotoxic
1
2010
63
0.080
 Why?
Heart Failure
1
2006
531
0.080
 Why?
Tissue Donors
3
2003
121
0.080
 Why?
Thrombosis
1
2003
250
0.080
 Why?
Vaccines, DNA
1
1999
12
0.080
 Why?
Erythroid Precursor Cells
1
2019
15
0.080
 Why?
Logistic Models
3
2017
901
0.080
 Why?
Reproducibility of Results
3
2017
1181
0.080
 Why?
Cisplatin
4
2006
283
0.080
 Why?
Birth Weight
1
2019
104
0.080
 Why?
Graft vs Host Reaction
1
1998
1
0.070
 Why?
Antigens, Neoplasm
2
2005
148
0.070
 Why?
Hematocrit
1
2018
42
0.070
 Why?
Survival Analysis
6
2006
658
0.070
 Why?
Salvage Therapy
3
2003
137
0.070
 Why?
Medical Waste
1
2017
2
0.070
 Why?
Cell Aggregation
1
2017
6
0.070
 Why?
Antineoplastic Agents, Alkylating
2
2008
73
0.070
 Why?
Arkansas
2
2017
1974
0.070
 Why?
Neutrophils
2
2006
142
0.070
 Why?
Program Evaluation
1
2019
351
0.070
 Why?
Lymphoma, Follicular
1
2017
20
0.070
 Why?
Neoplasm Proteins
2
2016
320
0.070
 Why?
Histocompatibility Antigens Class I
1
2017
46
0.070
 Why?
Antibodies, Monoclonal
2
2002
460
0.070
 Why?
Lymphocyte Activation
2
1995
169
0.070
 Why?
Infant, Newborn
2
2019
2752
0.070
 Why?
Fibrosis
1
2017
181
0.070
 Why?
Adolescent
5
2015
6453
0.060
 Why?
Dose-Response Relationship, Drug
3
2008
1369
0.060
 Why?
Reticulocyte Count
1
2006
5
0.060
 Why?
Tumor Escape
1
2006
17
0.060
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2017
90
0.060
 Why?
Curriculum
1
2019
393
0.060
 Why?
Mice
5
2018
5659
0.060
 Why?
Prostatic Neoplasms
1
1999
386
0.060
 Why?
Glucosylceramidase
1
1995
9
0.060
 Why?
Membrane Glycoproteins
3
2004
246
0.060
 Why?
Cytogenetic Analysis
2
2007
74
0.060
 Why?
Neutropenia
1
2006
116
0.060
 Why?
Hemoglobin J
1
2015
3
0.060
 Why?
Hemoglobin, Sickle
1
2015
6
0.060
 Why?
Hemoglobin C
1
2015
6
0.060
 Why?
Hematologic Neoplasms
1
1996
99
0.060
 Why?
Blood Donors
1
2015
21
0.060
 Why?
Clinical Protocols
2
2012
111
0.060
 Why?
Aged, 80 and over
3
2013
3233
0.060
 Why?
Diagnosis, Differential
1
2018
1029
0.060
 Why?
Cell Line
2
2008
997
0.060
 Why?
Tumor Necrosis Factor-alpha
2
2007
386
0.060
 Why?
Animals
7
2018
13063
0.050
 Why?
Base Sequence
3
1995
622
0.050
 Why?
Autoantibodies
1
2014
114
0.050
 Why?
Age Factors
3
2005
1118
0.050
 Why?
Specimen Handling
1
1994
55
0.050
 Why?
Molecular Sequence Data
3
1995
760
0.050
 Why?
Whole-Body Irradiation
4
1998
131
0.050
 Why?
Multivariate Analysis
3
2007
583
0.050
 Why?
Blotting, Western
1
2015
575
0.050
 Why?
Prednisone
2
2000
101
0.050
 Why?
Feasibility Studies
2
2011
389
0.050
 Why?
Interferon-gamma
2
2010
175
0.050
 Why?
CD4 Lymphocyte Count
1
2013
31
0.050
 Why?
Quality Assurance, Health Care
1
1994
149
0.050
 Why?
Pulmonary Fibrosis
2
1991
19
0.050
 Why?
Viral Load
1
2013
76
0.050
 Why?
Immunization, Passive
1
1992
30
0.050
 Why?
Transplantation Chimera
3
2003
14
0.050
 Why?
Pharmacokinetics
1
1992
17
0.050
 Why?
Cohort Studies
3
2006
1451
0.050
 Why?
Bone Marrow Purging
1
1992
2
0.050
 Why?
Haplotypes
2
2008
83
0.050
 Why?
Infection Control
1
1992
47
0.050
 Why?
Benzylamines
1
2012
15
0.050
 Why?
Receptors, CXCR4
1
2012
28
0.050
 Why?
Immunoglobulins
1
1992
80
0.050
 Why?
Immunohistochemistry
1
2015
955
0.050
 Why?
Recombinant Proteins
2
2008
477
0.050
 Why?
Heterocyclic Compounds
1
2012
29
0.050
 Why?
Urine
1
1991
24
0.050
 Why?
Kanamycin Kinase
2
1995
2
0.050
 Why?
Carmustine
1
2001
14
0.050
 Why?
Pneumonia, Pneumocystis
1
2001
7
0.050
 Why?
Lymphoma, Non-Hodgkin
1
2002
55
0.050
 Why?
Microscopy, Electron
1
2001
82
0.050
 Why?
Child
5
2015
6931
0.050
 Why?
Immune Tolerance
1
2011
83
0.050
 Why?
DNA Primers
2
1995
205
0.050
 Why?
Foscarnet
1
2001
2
0.050
 Why?
Tumor Cells, Cultured
2
1996
453
0.040
 Why?
Ganciclovir
1
2001
25
0.040
 Why?
Leukemia-Lymphoma, Adult T-Cell
1
2000
7
0.040
 Why?
Fatal Outcome
1
2001
197
0.040
 Why?
Cytomegalovirus
1
2001
28
0.040
 Why?
Quality Control
3
2005
97
0.040
 Why?
Antigens, Viral
1
2001
42
0.040
 Why?
Chimera
1
1990
10
0.040
 Why?
Isotonic Solutions
1
2010
17
0.040
 Why?
Syndrome
1
2001
236
0.040
 Why?
Neovascularization, Pathologic
1
2001
155
0.040
 Why?
Anemia, Aplastic
1
1990
11
0.040
 Why?
Transfection
3
1999
353
0.040
 Why?
P-Selectin
1
2010
31
0.040
 Why?
Virus Activation
1
2001
37
0.040
 Why?
Algorithms
2
2005
624
0.040
 Why?
Angiogenesis Inhibitors
2
2007
183
0.040
 Why?
Sodium Chloride
1
2010
56
0.040
 Why?
Platelet Aggregation
1
2010
70
0.040
 Why?
Platelet Activation
1
2010
46
0.040
 Why?
Predictive Value of Tests
2
2007
924
0.040
 Why?
Hypersensitivity
1
2010
76
0.040
 Why?
Peripheral Nervous System Diseases
1
1990
57
0.040
 Why?
Polyomavirus
1
1989
3
0.040
 Why?
Polymerase Chain Reaction
2
1995
447
0.040
 Why?
Leukemia, Myeloid, Acute
2
2007
180
0.040
 Why?
Antiviral Agents
1
2001
171
0.040
 Why?
Cystitis
1
1989
18
0.040
 Why?
Ultraviolet Rays
1
1989
48
0.040
 Why?
Glucocorticoids
1
2000
233
0.040
 Why?
Carrier Proteins
2
2004
297
0.040
 Why?
Pilot Projects
1
2000
694
0.040
 Why?
DNA
1
1991
534
0.040
 Why?
Nitric Oxide Synthase Type II
1
2018
63
0.040
 Why?
Ligands
1
2008
203
0.040
 Why?
Polyethylene Glycols
1
2008
84
0.040
 Why?
Arginase
1
2018
37
0.040
 Why?
Hemoglobins
1
2008
112
0.040
 Why?
Age Distribution
1
2007
172
0.030
 Why?
Theophylline
1
2007
22
0.030
 Why?
Antineoplastic Agents, Hormonal
1
2007
49
0.030
 Why?
Multigene Family
1
2006
46
0.030
 Why?
Chromosome Deletion
1
2007
134
0.030
 Why?
Chromosome Mapping
1
2006
143
0.030
 Why?
In Situ Hybridization, Fluorescence
1
2007
231
0.030
 Why?
Apoptosis
1
2001
1092
0.030
 Why?
Benzopyrenes
1
1975
2
0.030
 Why?
3T3 Cells
1
1995
56
0.030
 Why?
Epithelium
1
1975
66
0.030
 Why?
Cytotoxicity, Immunologic
1
1995
57
0.030
 Why?
Interleukin-2
1
1995
70
0.030
 Why?
Interleukin-10
1
2006
84
0.030
 Why?
Cell Communication
1
2006
70
0.030
 Why?
Liver
1
2001
1126
0.030
 Why?
Neoplasms, Experimental
1
2006
111
0.030
 Why?
Life Tables
2
2002
9
0.030
 Why?
Stroke Volume
1
2006
141
0.030
 Why?
Ficoll
2
1996
2
0.030
 Why?
Myocardial Ischemia
1
2006
112
0.030
 Why?
Ventricular Dysfunction, Left
1
2006
107
0.030
 Why?
Databases, Factual
1
2007
676
0.030
 Why?
Mice, Transgenic
1
2006
537
0.030
 Why?
Bromodeoxyuridine
1
2004
18
0.030
 Why?
Receptor Activator of Nuclear Factor-kappa B
1
2004
32
0.030
 Why?
Annexin A5
1
2004
14
0.030
 Why?
Culture Media, Conditioned
1
2004
46
0.030
 Why?
Epithelial Cells
1
1975
203
0.030
 Why?
Immunotherapy
2
2002
234
0.030
 Why?
Phagocytosis
1
2004
49
0.030
 Why?
Survival Rate
1
2006
906
0.030
 Why?
Fluorescent Antibody Technique, Indirect
1
2003
20
0.030
 Why?
Syndecans
1
2003
35
0.030
 Why?
Chronic Disease
1
2006
573
0.030
 Why?
Paraproteins
1
2003
13
0.030
 Why?
Cell Division
1
2004
292
0.030
 Why?
Ifosfamide
2
1993
11
0.030
 Why?
Syndecan-1
1
2003
73
0.030
 Why?
Plasmapheresis
1
2003
11
0.030
 Why?
Immunoenzyme Techniques
1
2003
140
0.030
 Why?
Proteoglycans
1
2003
81
0.030
 Why?
Interleukin-6
1
2004
261
0.030
 Why?
RANK Ligand
1
2004
186
0.030
 Why?
Severity of Illness Index
1
2006
976
0.020
 Why?
NF-kappa B
1
2004
306
0.020
 Why?
Infusions, Intravenous
2
2003
212
0.020
 Why?
Remission Induction
2
2003
208
0.020
 Why?
Drug Administration Schedule
2
2003
373
0.020
 Why?
Red-Cell Aplasia, Pure
1
2002
7
0.020
 Why?
Blood Transfusion, Autologous
2
1992
6
0.020
 Why?
Cell Differentiation
1
2004
640
0.020
 Why?
Graft Rejection
1
2002
173
0.020
 Why?
Disease Models, Animal
1
2006
1431
0.020
 Why?
Colony-Forming Units Assay
2
1992
25
0.020
 Why?
Immunoglobulin Idiotypes
1
2010
5
0.020
 Why?
CD40 Ligand
1
2010
14
0.020
 Why?
Drug Resistance, Neoplasm
2
2003
315
0.020
 Why?
Hypersensitivity, Delayed
1
2010
18
0.020
 Why?
Interleukin-4
1
2010
42
0.020
 Why?
Immunity, Cellular
1
2010
68
0.020
 Why?
Adjuvants, Immunologic
1
2010
52
0.020
 Why?
Magnetic Resonance Imaging
1
2007
1546
0.020
 Why?
Child, Preschool
3
1994
3953
0.020
 Why?
Biotechnology
1
1999
13
0.020
 Why?
Immunologic Surveillance
1
1999
11
0.020
 Why?
B-Lymphocytes
1
2010
171
0.020
 Why?
Drug Resistance
1
1998
65
0.020
 Why?
Steroids
1
1998
57
0.020
 Why?
Chromatography, Gas
1
1998
15
0.020
 Why?
Vaccination
1
2010
275
0.020
 Why?
Secondary Prevention
1
1998
80
0.020
 Why?
Neomycin
1
1997
4
0.020
 Why?
Drug Resistance, Microbial
1
1997
45
0.020
 Why?
Rats
2
1998
3262
0.020
 Why?
Stromal Cells
1
1997
75
0.020
 Why?
Leukemia, Erythroblastic, Acute
1
1996
5
0.020
 Why?
Centrifugation, Density Gradient
1
1996
23
0.020
 Why?
Solutions
1
1996
25
0.020
 Why?
Indicators and Reagents
1
1996
37
0.020
 Why?
Clone Cells
1
2006
72
0.020
 Why?
Deoxycytidine
1
2006
28
0.020
 Why?
Temperature
1
1996
157
0.020
 Why?
Genes
1
1995
32
0.020
 Why?
Transduction, Genetic
1
1995
45
0.020
 Why?
In Situ Hybridization
1
1995
66
0.020
 Why?
Chromatography, Affinity
1
1995
39
0.010
 Why?
Fluorouracil
1
1995
59
0.010
 Why?
Genes, Reporter
1
1995
87
0.010
 Why?
Genetic Markers
1
1995
104
0.010
 Why?
Recovery of Function
1
2006
191
0.010
 Why?
Mice, Inbred BALB C
1
1995
293
0.010
 Why?
Lymphocyte Subsets
1
1994
14
0.010
 Why?
Kinetics
1
2006
634
0.010
 Why?
Macaca mulatta
1
1994
97
0.010
 Why?
Propidium
1
1994
3
0.010
 Why?
T-Lymphocyte Subsets
1
1994
38
0.010
 Why?
Mutation
1
1999
1275
0.010
 Why?
Immunophenotyping
1
1994
106
0.010
 Why?
Oligodeoxyribonucleotides
1
1993
33
0.010
 Why?
Stem Cell Factor
1
2003
7
0.010
 Why?
Confidence Intervals
1
2003
155
0.010
 Why?
Cell Death
1
1994
175
0.010
 Why?
Probability
1
2003
163
0.010
 Why?
Cell Nucleus
1
1994
183
0.010
 Why?
Data Interpretation, Statistical
1
1994
162
0.010
 Why?
Leukocyte Count
1
2003
71
0.010
 Why?
Academic Medical Centers
1
1994
147
0.010
 Why?
Carboplatin
1
1992
54
0.010
 Why?
Multiple Organ Failure
1
2002
48
0.010
 Why?
Neoplasm Metastasis
1
1993
230
0.010
 Why?
Injections, Intravenous
1
1992
137
0.010
 Why?
Statistics as Topic
1
1992
86
0.010
 Why?
Administration, Oral
1
2003
438
0.010
 Why?
Leukopenia
1
1992
8
0.010
 Why?
Blood Cell Count
1
1992
39
0.010
 Why?
Antibodies, Monoclonal, Murine-Derived
1
2002
44
0.010
 Why?
Doxorubicin
1
2003
235
0.010
 Why?
Linear Models
1
1992
283
0.010
 Why?
Proportional Hazards Models
1
1992
416
0.010
 Why?
Neoplasm Staging
1
2003
738
0.010
 Why?
Pedigree
1
1990
119
0.010
 Why?
HLA Antigens
1
1990
52
0.010
 Why?
Bacterial Infections
1
1991
98
0.010
 Why?
Muscle Cramp
1
1990
6
0.010
 Why?
Software
1
1992
268
0.010
 Why?
Mycoses
1
1991
159
0.010
 Why?
Postoperative Period
1
1990
171
0.010
 Why?
Sepsis
1
2002
225
0.010
 Why?
Disease Progression
1
2003
825
0.010
 Why?
Busulfan
1
1989
19
0.010
 Why?
Tumor Virus Infections
1
1989
47
0.010
 Why?
Hematopoiesis
1
1989
72
0.010
 Why?
Dose-Response Relationship, Radiation
1
1989
183
0.010
 Why?
Glycols
1
1975
3
0.010
 Why?
Quinones
1
1975
9
0.010
 Why?
Hydrocortisone
1
1975
110
0.010
 Why?
Phenols
1
1975
82
0.010
 Why?
Microsomes, Liver
1
1975
183
0.010
 Why?
Fibroblasts
1
1975
338
0.010
 Why?
Cells, Cultured
1
1975
1563
0.010
 Why?
Infant
1
1990
3648
0.010
 Why?
Fox's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (437) concept(s)
_
Co-Authors Expand Description
See all (27) people
_
Similar People Expand Description
See all (34) people
_
Same Department Expand Description
Search Department